دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Keeping a Safe Distance From Surgical Volume Standards.
Heiden, Brendan T. MD, MPHS 1,2,; Kozower, Benjamin D. MD, MPH 1,3
doi : 10.1200/JCO.21.02875
Volume 40(10) pgs. 1033-1134 April 1, 2022
Call to Action for Improving Oral Anticancer Agent Adherence.
Levit, Laura A. JD 1,; Arora, Shaily PharmD 2; Kluetz, Paul G. MD 3; Magnuson, Allison DO 4; Rahman, Atiqur PhD 3; Harvey, R. Donald PharmD 5,
doi : 10.1200/JCO.21.02529
Risk-Adjusted Mortality Rates as a Quality Proxy Outperform Volume in Surgical Oncology-A New Perspective on Hospital Centralization Using National Population-Based Data.
Baum, Philip MD 1,2,; Lenzi, Jacopo PhD 3; Diers, Johannes MD, MScPH 2,; Rust, Christoph MSc 4,5; Eichhorn, Martin E. MD 1,6,; Taber, Samantha MD 7; Germer, Christoph-Thomas MD 2,8; Winter, Hauke MD 1,6,; Wiegering, Armin MD 2,8,9
doi : 10.1200/JCO.21.01488
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.
Joensuu, Heikki MD 1,,; Kellokumpu-Lehtinen, Pirkko-Liisa MD 2; Huovinen, Riikka MD 3,; Jukkola, Arja MD 2,4; Tanner, Minna MD 2,; Ahlgren, Johan MD 5,6; Auvinen, Paivi MD 7; Lahdenpera, Outi MD 3; Villman, Kenneth MD 8; Nyandoto, Paul MD 9; Nilsson, Greger MD 10,; Poikonen-Saksela, Paula MD 1; Kataja, Vesa MD 11,; Bono, Petri MD 1,; Junnila, Jouni MSc 12; Lindman, Henrik MD 13,
doi : 10.1200/JCO.21.02054
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study).
Postow, Michael A. MD 1,2,,; Goldman, Debra A. MS 1,; Shoushtari, Alexander N. MD 1,2,; Betof Warner, Allison MD, PhD 1,2,; Callahan, Margaret K. MD, PhD 1,2,; Momtaz, Parisa MD 1,2; Smithy, James W. MD 1,2; Naito, Ellesa BS 1; Cugliari, Marina K. BS 1; Raber, Vladislav 1; Eton, Omar MD 3,; Nair, Suresh G. MD 4,; Panageas, Katherine S. DrPh 1,; Wolchok, Jedd D. MD, PhD 1,2,; Chapman, Paul B. MD 1,2,
doi : 10.1200/JCO.21.01570
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.
Pires da Silva, Ines MD, PhD 1,2,3,; Ahmed, Tasnia MSc 1; McQuade, Jennifer L. MD, PhD 4,; Nebhan, Caroline A. MD 5; Park, John J. MD 6; Versluis, Judith M. MD 7; Serra-Bellver, Patricio MD 8; Khan, Yasir MD 8; Slattery, Tim MD 9; Oberoi, Honey K. MD 10; Ugurel, Selma MD 11,; Haydu, Lauren E. MD, PhD 3; Herbst, Rudolf MD 12,; Utikal, Jochen MD 13,14,; Pfohler, Claudia MD 15,; Terheyden, Patrick MD 16,; Weichenthal, Michael MD 17,; Gutzmer, Ralf MD 18,; Mohr, Peter MD 19,; Rai, Rajat MD 1; Smith, Jessica L. MD 3,; Scolyer, Richard A. MD 1,2,20,21,; Arance, Ana M. MD, PhD 10,; Pickering, Lisa MD, PhD 9,; Larkin, James MD, PhD 9,; Lorigan, Paul MD 8,22,; Blank, Christian U. MD, PhD 7,; Schadendorf, Dirk MD, PhD 11,; Davies, Michael A. MD, PhD 4,; Carlino, Matteo S. MD, PhD 1,3,; Johnson, Douglas B. MD 5,; Long, Georgina V. MD, PhD 1,2,23,; Lo, Serigne N. PhD 1; Menzies, Alexander M. MD, PhD 1,23,,
doi : 10.1200/JCO.21.01701
Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers.
Franco, Aime T. PhD 1; Ricarte-Filho, Julio C. PhD 1; Isaza, Amber BA 1; Jones, Zachary BS 1,+; Jain, Neil BS 1; Mostoufi-Moab, Sogol MD, MSCE 1,2; Surrey, Lea MD 3,; Laetsch, Theodore W. MD 2,; Li, Marilyn M. MD 3; DeHart, Jessica Clague PhD 4; Reichenberger, Erin PhD 5; Taylor, Deanne PhD 5; Kazahaya, Ken MD, MBA 6,7,; Adzick, N. Scott MD 7; Bauer, Andrew J. MD 1,,
doi : 10.1200/JCO.21.01861
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
Casasnovas, Rene-Olivier MD 1,,; Bouabdallah, Reda MD 2,3; Brice, Pauline MD 4,; Lazarovici, Julien MD 5,; Ghesquieres, Herve MD, PhD 6,; Stamatoullas, Aspasia MD 7,; Dupuis, Jehan MD 8,; Gac, Anne-Claire MD 9; Gastinne, Thomas MD 10,; Joly, Bertrand MD 11; Bouabdallah, Krimo MD 12,; Nicolas-Virelizier, Emmanuelle MD 13; Feugier, Pierre MD, PhD 14,; Morschhauser, Franck MD, PhD 15,; Sibon, David MD 16,; Bonnet, Christophe MD 17,; Berriolo-Riedinger, Alina MD 18; Edeline, Veronique MD 19; Parrens, Marie MD 20; Damotte, Diane MD, PhD 21,; Coso, Diane MD 2; Andre, Marc MD, PhD 22,23,; Meignan, Michel MD 24,; Rossi, Cedric MD, PhD 1,
doi : 10.1200/JCO.21.01777
Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny Labeling.
Walsh, Bryan S. JD 1; Kesselheim, Aaron S. MD, JD, MPH 1; Sarpatwari, Ameet PhD, JD 1,; Rome, Benjamin N. MD, MPH 1,,
doi : 10.1200/JCO.21.02139
Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care.
Di Meglio, Antonio MD, PhD 1,2; Havas, Julie MSc 1; Soldato, Davide MD 1,3; Presti, Daniele MD 1,4; Martin, Elise PhD 1; Pistilli, Barbara MD 1,2,; Menvielle, Gwenn PhD 5; Dumas, Agnes PhD 6; Charles, Cecile PhD 1; Everhard, Sibille PhD 7; Martin, Anne-Laure PhD 7; Coutant, Charles MD 8; Tarpin, Carole MD 9; Vanlemmens, Laurence MD 10; Levy, Christelle MD 11; Rigal, Olivier MD 12; Delaloge, Suzette MD 1,2,; Lin, Nancy U. MD 13,; Ganz, Patricia A. MD 14,; Partridge, Ann H. MD 13,; Andre, Fabrice MD, PhD 1,2,; Michiels, Stefan PhD 15,16,; Vaz-Luis, Ines MD, PhD 1,2,,
doi : 10.1200/JCO.21.01252
Age of Onset of Receptor Tyrosine Kinase Fusions Drives Distinct Biologic Outcomes in Thyroid Cancer.
Fagin, James A. MD 1,,
doi : 10.1200/JCO.21.02864
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.
Pisters, Katherine MD 1; Kris, Mark G. MD 2,; Gaspar, Laurie E. MD 3,4,; Ismaila, Nofisat MD 5,; for the Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA NSCLC Guideline Expert Panel
doi : 10.1200/JCO.22.00051
Reply to S. Acharya.
Chopra, Supriya MBBS, MD; Kannan, Sadhana MSc; Gupta, Sudeep MD, DM
doi : 10.1200/JCO.21.02816
Transoral Surgery With Neck Dissection Is an Excellent Treatment for the Appropriately Selected Patient With Early-Stage Oropharyngeal Cancer.
Garden, Adam S. MD
doi : 10.1200/JCO.21.02630
Reply to A.S. Garden.
Ferris, Robert L. MD, PhD; Burtness, Barbara MD; Flamand, Yael PhD
doi : 10.1200/JCO.22.00063
